Search

Search Results

• 

  A randomized, multicenter, controlled study, comparing efficacy and safety of a new complementary and alternative medicine (CAM) versus Solifenacin Succinate in women with overactive bladder syndrome

  Carlo Vecchioli-Scaldazza, Carolina Morosetti, Serena Maruccia, Stefano Casellato, Wilma Rociola, Ester Illiano, Francesco Garofalo

  296-300

  2017-12-31

  Published: December 31, 2017

  2457

  PDF: 1440

• Differences in bladder neck angles between female patients with overactive bladders and healthy peers

  Mehmet Yoldas, Mehmet Zeynel Keskin

  2024-06-27

  Published: June 27, 2024

  496

  PDF: 221
• 

  Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials

  Rawa Bapir, Kamran Hassan Bhatti, Ahmed Eliwa, Herney Andrés García-Perdomo, Nazim Gherabi, Derek Hennessey, Vittorio Magri, Panagiotis Mourmouris, Adama Ouattara, Gianpaolo Perletti, Joseph Philipraj, Konstantinos Stamatiou, Alberto Trinchieri, Noor Buchholz

  492-506

  2022-12-28

  Published: December 28, 2022

  6431

  PDF: 3987

  Supplementary Material: 145

• Role of urine glycosaminoglycan levels in the diagnosis and follow-up in men with lower urinary tract symptoms

  Hasan Riza Aydin, Cagri Akin Sekerci, Huseyin Kocakgol, Banu Isbilen Basok, Fevzi Bedir, Ahmet Ozgur Guctas, Firat Akdeniz, Hamit Zafer Aksoy, Mehmet Akif Ramazanoglu, Yiloren Tanidir

  2024-05-09

  Published: May 9, 2024

  504

  PDF: 174
• 

  The choice of therapeutic agent in female overactive bladder patients in real-world practice

  Hiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, Kyokusin Hou, Takahito Suyama, Kazuhiro Araki, Satoko Kojima, Yukio Naya

  451-454

  2022-12-27

  Published: December 27, 2022

  497

  PDF: 257
• 

  Are voiding volumes and frequencies different in the three-day voiding diary in children with lower urinary tract dysfunction?

  Raziye Ergun, Cagri Akin Sekerci, Mehmet Cetin, Mohammad Yasir Sahak, Selcuk Yucel, Tufan Tarcan

  2023-10-03

  Published: October 3, 2023

  501

  PDF: 389
• 

  The role of Protopine associated with Nuciferine in controlling adverse events during hyperthermic intravesical chemotherapy instillations. A nutraceutical approach to control adverse event during intravesical instillations

  Francesco Chiancone, Maurizio Carrino, Maurizio Fedelini, Marco Fabiano, Francesco Persico, Clemente Meccariello, Paolo Fedelini

  2020-10-01

  Published: October 1, 2020

  1351

  PDF: 958
• 

  Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study

  Ferdinando Fusco, Massimiliano Creta, Francesco Trama, Fabio Esposito, Felice Crocetto, Achille Aveta, Francesco Mangiapia, Ciro Imbimbo, Marco Capece, Roberto La Rocca, Vincenzo Mirone, Nicola Longo

  2020-10-01

  Published: October 1, 2020

  1647

  PDF: 1088
• 

  The role of anticholinergic therapy based on the upoint system in the treatment of chronic prostatitis

  Kamil Fehmi Narter, Utku Can, Alper Coşkun, Kubilay Sabuncu, Fatih Tarhan

  16-21

  2019-03-29

  Published: March 29, 2019

  1356

  PDF: 782

• Reliability and validity analysis of Turkish version of the Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-10 questionnaire

  Serkan Akan, Hasan Huseyin Tavukcu, Meftun Culpan, David Cella

  2024-05-17

  Published: May 17, 2024

  544

  PDF: 196